Volume 74, Number 18, May 4, 2010
About this course
- Released: 05/03/2010
- Expires: 05/04/2012
Learning Objectives:
Upon completion of the article by Clarke et al., the participant should be able to:
• State a reason why the diagnosis of leptomeningeal metastases (LM) has become increasingly common.
• State the most common cancer associated with LM.
• State the percentage of patients in which the diagnosis of LM was established by neuroimaging when the CSF examination was negative.
Core Competencies:
The article by Clarke et al. covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Marriott et al., the participant should be able to:
• Describe a mechanism of action by which mitoxantrone reduces lymphocyte proliferation.
• State the level of evidence supporting the efficacy of using mitoxantrone to treat multiple sclerosis (MS).
• State the approximate rate of altered left ventricular ejection fraction (LVEF) associated with the use of mitoxantrone.
Core Competencies:
The article by Marriott et al. covers the following core competency:
•Medical Knowlege
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
